Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis.
about
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantationPrevention and Treatment of Recurrent Hepatitis B after Liver TransplantationChange of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationHepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcomeIs hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysisAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantationImmunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infectionClinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.Identification of HBsAg-specific antibodies from a mammalian cell displayed full-length human antibody library of healthy immunized donorDowngrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failureHepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up.Genetic polymorphism of interferon regulatory factor 5 (IRF5) correlates with allograft acute rejection of liver transplantation.Complete withdrawal of hepatitis B virus prophylaxis after liver transplantation in a recipient at high risk of recurrence.Prophylaxis of hepatitis B infection in solid organ transplant recipients.Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular CarcinomaA case report of de novo hepatocellular carcinoma after living donor liver transplantationHepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitroCurrent prophylactic strategies against hepatitis B virus recurrence after liver transplantation.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.Treatment of special populations with chronic hepatitis B infection.Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation.Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.Management of hepatitis B virus infection after liver transplantation.Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma.The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative.
P2860
Q24234338-97C3C498-F30F-42B6-B11A-997F93F1C2E4Q26751777-60F1476C-27E5-433B-A68B-CA2FA5A507ECQ26784241-AF405B71-0938-43A4-AAE9-A9CC158CDE17Q26859121-42CB772A-415A-49A3-9D23-9AB1E1819C6DQ26996086-60B2B691-D663-4DDD-93BB-C2A13AFE369FQ30391932-7EE20A88-A106-43E6-B3BA-CC7915712B7EQ30431207-958B7922-BE23-498E-8879-E5739B5F0271Q33418708-EFC2B5CF-E238-407A-A24C-466A02126DC1Q33624284-1A2C15BD-0235-45BB-8456-4DC2CF0FA4DFQ33649970-6BD6765B-737D-41EA-8B69-588575CF331EQ33725558-E6FB274A-B4B6-46AA-A730-6CA811EB8E8CQ34029115-405BEF50-73BB-4D83-8488-426CEE807F67Q34104779-AABF7B93-3AF5-4DBD-94DF-1FFF666B5633Q34145990-2C82C1EA-DB02-4477-9DEB-CA928A7956A6Q34175570-C8DFB0D5-CB18-49A4-AA6C-9F7BBB0274FBQ34442045-F496702F-6B98-45CF-9DCE-07C322F034AEQ35161570-AAB560FC-F27A-4132-8EF4-3F3EBABB519AQ35871151-81829BE0-7467-456A-B070-11A33531F677Q36886518-8E148139-F96B-4108-85F0-DC0D7E35C472Q37066388-4FD4B277-0F04-4DE8-B564-57D5300BFF03Q37116722-2DF173D5-AA82-40C5-8F85-CA54CE8E0283Q37137539-8B8A266F-1BB6-4E51-93B3-EE04C6846BF3Q37495757-B2E8D594-CA19-428B-8057-9869C127CB94Q37764964-60DA2665-09B3-4704-9365-6ABDAD299F5FQ37870833-DF16D9E7-2192-4BFC-8D82-F6E05F155153Q37886158-6B1D7B4E-B0B3-4329-A19F-4096061BCDA0Q37886893-D654D066-E62D-44EF-B43C-8A8C6385AAA6Q37905782-C4C0C33A-D578-4A77-9D99-FE68A364F7C1Q37982346-8DC231D8-EADF-4BEE-9504-1E4F8E0A4A38Q38006958-3462A717-2C23-438D-B0B4-957820AA64B2Q38058545-26808C2B-08D1-473B-8D42-B5CC22937B91Q38121508-5F0F00DA-2084-4CF2-897A-27CBE8ECCA10Q38137238-46C782DC-0463-47F2-B253-6A6451451BF5Q38177252-EA1AD47B-296F-4D22-BF4D-D0484C0C779EQ38218762-0EC5EF9B-4C0C-4112-9810-FE335CAB7416Q38514411-704BABE4-B508-4D74-ACCB-3E187CD7F278Q38635614-4BB95CF5-D0CD-42B6-919D-CC60A5D54E30Q39126394-34D2056F-D707-4A6E-AB38-05BF9E9D94AAQ40654117-4440D5F9-A46A-401B-83C2-CBC4CF686873Q41755402-D315FC7B-5D54-444F-A76A-979B20141F4A
P2860
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@ast
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@en
type
label
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@ast
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@en
prefLabel
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@ast
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@en
P2093
P356
P1476
Prevention of hepatitis B recu ...... B Immunoglobulin prophylaxis.
@en
P2093
Shusen Zheng
Tingbo Liang
Weilin Wang
Yaomin Chen
P304
P356
10.1002/LT.20701
P577
2006-02-01T00:00:00Z